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Project Summary:
Early Life Stress (ELS) is associated with an increased vulnerability to developing
mood disorder later in life (35). While many of the structural and neurochemical
consequences of ELS have been studied, it is not well understood how these
changes may translate to the deficits in cognitive and affective function associated
with mood disorders. The constitutively active Protein Kinase C kinase isoform
Protein Kinase M zeta (PKMzeta) has a critical role in the molecular mechanisms of
long-term potentiation (LTP) maintenance (1, 2), and memory storage. Recent
preclinical studies indicate PKMzeta expression at the synaptic membrane directly
mediates cognitive processing in the hippocampus (33, 34). Building on our previous
findings of serotonergic dysfunction and hippocampal hypotrophism in the highly
clinically relevant Variable Foraging Demand (VFD) Non-Human Primate (NHP)
model of ELS, the current study aims to further characterize the ELS phenotype with
respect to this key marker of hippocampal LTP. Furthermore, we have recently
presented evidence of impaired neurogenesis in the VFD dentate gyrus compared to
non-VFD reared animals subjected to chronic adult stress (93) suggesting that ELS
and concurrent adult stress affect hippocampal processes differentially. In the
current report, we utilize our extensive NHP tissue bank, which includes
hippocampal samples from animals subjected to ELS and chronic adult stress,
respectively, in order to explore these differential effects of ELS vs. concurrent stress
on hippocampal LTP, and the implications of those effects on cognitive aspects of
stress-related depressive symptoms in NHPs.
This is the first report of PKMzeta detection and analysis in the NHP brain – an
important model for translational psychiatric research. We hypothesize that ELS
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rearing is associated with reduced PKMzeta expression, and that this effect may be
linked to cognitive deficits often observed in animal and clinical studies of ELS.
Semi-quantitative evaluation of PKMzeta signal intensity via neuroimmunostaining
across defined subregions in the NHP hippocampus will allow us to assess the
effects of differential rearing conditions and stress paradigms on key components of
hippocampal LTP maintenance as a consequence of ELS versus concurrent adult
stress. We further hypothesize, based on recent mechanistic reports, that PKMzeta
expression in the hippocampus is interconnected with both serotonergic signaling
and Brain-derived Neurotrophic Factor (BDNF) expression – two critically important
processes involved in hippocampal function (94). Importantly, our NHP cohort
includes bonnet macaques harboring both the “long” and “short” alleles of the
serotonin transporter gene polymorphism. The “short” STG allele produces a
functional serotonin transporter with reduced capacity leading to reduced serotonin
signaling, allowing us to observe how impaired serotonergic signaling may interact
with rearing conditions to affect expression of these markers.
Finally, we hypothesize that reduced PKMzeta in ELS subjects may manifest in
behavioral alterations in adulthood. Previous studies in rodents and primates have
definitively shown that PKMzeta expression in the hippocampus has a direct effect
on cognition and behavior (33, 34). Thus, by correlating hippocampal PKMzeta
signal intensities with previously obtained behavioral data from this same cohort, we
aim to delineate the neurobiological phenotype of altered hippocampal processing in
the NHP model of ELS – further linking the distribution and activity of the molecular
substrate of L-LTP to its behavioral and physiological manifestations.
While many studies have utilized PKMzeta localization as a tool for identifying
maintenance of spatial memory in the rodent dorsal hippocampus (20), few have
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examined the distribution of PKMzeta in the non-human primate brain or attempted
to investigate the role of PKMzeta in the affective processing circuits of the
hippocampus (25). Nonhuman primates provide a powerful model in which to use
postmortem analyses to identify the mechanisms by which early stress and genetic
makeup interact to produce long-term changes in brain development, stress
reactivity, and risk for psychiatric disorders. Improved understanding of these
processes will likely lead to the development of novel strategies for the prevention
and treatment of neuropsychiatric disorders.

Specific Aims:
1. Assess differential patterns of PKMzeta expression in the NHP hippocampus by
quantifying average PKMzeta signal intensity in specific subregions to detect
alterations in VFD animals compared to control. We are particularly interested in
exploring the role of serotonergic signaling, a key monoamine implicated in
depression, in mediating PKMzeta expression. We will examine PKMzeta signal
intensity in differentially reared subjects harboring the “Long” versus “Short”
polymorphic alleles of the Serotonin Transporter Gene (STG) promoter.
2. Determine how PKMzeta expression in VFD subjects compares to hippocampal
PKMzeta expression in concurrent adult stress subjects, in order to finely define
specific phenotypes of early life stress versus adult stress.
3. Quantify the BDNF concentration in key sub-groups of our extensive NHP cohort in
order to determine if there is a relationship between PKMzeta and BDNF expression,
potentially indicating a role for neurotrophic deficits in the cognitive symptoms of
stress-induced affective dysregulation. Results from this analysis may indicate if the
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neurobiological alterations we have previously observed in VFD models of ELS are
associated with cognitive processes.
4. Correlate previously collected data, including maladaptive behavioral response to
intruder stressors, from this same cohort of NHPs to the quantification of PKMzeta
concentration distribution across the hippocampus with the goal of determining the
extent to which the consistent VFD maladaptive behavioral phenotype is linked to
LTP maintenance in the hippocampus.

Background:
Protein Kinase M Zeta and the Molecular Mechanisms of LTP Maintenance
Molecular Mechanism of PKMzeta in LTP maintenance
One of the most exciting recent discoveries in the field of molecular neuroscience is
the identification of constitutively active atypical PKC kinase isoform PKMzeta as a
critical factor in the molecular mechanism of late-phase long-term potentiation (LTP)
maintenance (1,2). LTP is an activity-dependent and persistent strengthening of
synaptic transmission, and one of the most likely candidate processes underlying
long-term memory (3). This potentiation is achieved through a complex set of
intracellular molecular signaling cascades that ultimately converges on the synaptic
machinery responsible for increasing the number of excitatory α-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid glutamate receptors (AMPAR) in the post-synaptic
density of the neuronal cell membrane (4). LTP can be separated into two distinct
phases: the initial induction phase triggers potentiation, and involves the rapid
synthesis and activation of calcium-dependent proteins to quickly enact the structural
and proteomic changes required for modulating synaptic plasticity (5,6). Importantly,
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many of the molecules that were discovered to be important to forming long-term
memory, such as neurotransmitters and their receptors, Ca2+-dependent second
messenger kinases, and downstream transcription factors and growth effectors were
found to be critical for LTP induction, but not required for the second and longerlasting maintenance phase (76). Inhibiting any of these LTP induction factors does
not affect storage of previously consolidated memory (6, 76). Instead, the process of
LTP induction is thought to coincide with memory encoding, while the second and
longer-lasting LTP maintenance phase sustains storage of a distributed long-term
memory engram (6). Recently, it was discovered by Dr. Todd Sacktor’s group at
SUNY Downstate that the persistently active protein kinase C isoform PKMzeta is
both necessary and sufficient to maintain LTP and memory storage (8,19). This
atypical PKC isoform has several unique characteristics that specify its central
function in sustaining synaptic potentiation. PKMzeta is exclusively expressed in
brain tissue and is specifically enriched in the forebrain, particularly in the
hippocampus and neocortex (9). Furthermore, the PKMzeta isoform is transcribed
from an internal promoter at the PKC locus, and thus lacks the autoinhibitory domain
of typical PKC molecules, allowing it to autonomously and continuously
phosphorylate its target substrates (10). Importantly, this unique persistent catalytic
activity is the basis for PKM z’s role in long-term LTP maintenance.

6

Figure 1: Shows a graphic model of the inactive and active conformations of the typical PKC kinase
and the truncated PKM. PKC consists of a C-terminal catalytic domain (green) tethered by a hinge (yellow)
to an N-terminal regulatory domain (red), which contains an autoinhibitory pseudosubstrate sequence. PKC
is maintained in an inactive state by the interaction between the pseudosubstrate and the catalytic site. PKC
is activated by second messengers, which produce a conformational change that releases the autoinhibition.
PKM is the independent catalytic domain of PKC, synthesized from an internal promoter at the PKC gene
locus. Because PKM lacks a regulatory domain, it is constitutively active. [Taken from Ref. 73]

Figure 2: PKMζ mRNA formation from an internal promoter within the PKCζ gene : The intron-exon
structure of the human PKCZ gene shows two exon clusters separated by a large intron: exons 1-4,
encoding the PKCZ 5’UTR (in light blue) and regulatory domain ( in red), and exons 5-18, encoding the
remaining regulatory domain, hinge (yellow), catalytic domain (green), and 3’ UTR (grey). The unique 5’
PKMζ mRNA sequence is in a single exon (exon 1’, dark blue) within the large intron. PKCζ mRNA
transcription begins at exon 1. PKMzeta transcription is initiated from exon 1’ and alternative splicing to exon
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5 generates PKMζ mRNA. [Taken from Ref. 73]

At the synapse, the strength of signal transmission between two neurons is tightly
regulated to preserve relevant connections and degrade irrelevant ones. At resting
state, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs)
cation channels are a main regulator of synaptic membrane depolarization
thresholds and are constantly removed from the membrane and targeted for
degradation by the ubiquitin-proteasome pathways that work to recycle proteins in
the dendritic compartment (9). The constitutive PKMzeta kinase appears to sustain
LTP maintenance after induction through regulating AMPA Glutamate receptor 2
(GluR2)-subunit dependent ionotropic receptor trafficking at the post-synaptic
density (10) and preventing AMPAR endocytosis and degradation, in order to
generate non-decaying LTP (11). The mechanistic details of this process are just
now beginning to be understood: PKMzeta interacts directly with activity-dependent
factors that traffic excitatory AMPA-glutamate receptors to the membrane during LTP
induction (12). The kinase maintains LTP by acting on the N-ethylmaleimidesensitive factor (NSF) - Protein Interacting with C Kinase – 1 (PICK1) AMPA
receptor trafficking pathway to increase intracellular trafficking of the GluR2 subunitcontaining AMPA receptor to the postsynaptic density following LTP induction,
thereby potentiating the postsynaptic intracellular response to future excitatory
neurotransmitter signaling at a given synapse (9,13).
In the past few years, mounting evidence has demonstrated the importance
of PKMzeta in LTP maintenance and long-term memory storage. Many of these
studies have utilized the ζ-pseudosubstrate inhibitory peptide (ZIP), a specific
inhibitor of PKMzeta, to disrupt PKMzeta activity. In a wide range of preclinical
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investigations, microinjection of ZIP into specific brain regions abolishes both spatial
memory and fear conditioned memories for up to three months post-training, far
longer than the average half-life of the PKMzeta protein (14,15). In order to preserve
synaptic potentiation for these long periods, PKMzeta must be continuously
produced and upregulated locally to constantly work against this recycling process in
neurons actively participating in long-term memory, (16) thus making it an excellent
potential marker of long-term information storage and preferred processing pathways
in memory circuitry.

Figure 3: Model of LTP maintenance by PKMζ synthesis. Activation by the excitatory
neurotransmitter glutamate (Glu) at the NMDA receptor (NMDAR) during a tetanus triggers the induction of
PKMζ formation. PKMζ phosphorylation potentiates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate
receptor (AMPAR) mediated synaptic transmission in LTP maintenance. Formation of PKMζ during LTP
occurs through increased de novo protein synthesis from the PKMζ mRNA, produced by a dedicated internal
promoter within the PKCζ gene. Potential activity-dependent regulatory mechanisms for PKMζ formation
include enhanced transcription by CREB and increased local translation. [Taken from Ref. 73]
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PKMzeta as a Marker of Neuronal Activation and Potential Indicator of Memory
Engram
PKMzeta is preferentially expressed in the hippocampus as a downstream target of
many major signaling cascades in response to neuronal activation (1). Since the
identification of PKMzeta as the major synaptic molecule responsible for LTP
maintenance, two contrary studies have suggested that PKMzeta null mice are still
capable of maintaining long-term memory (17), implying that the ZIP inhibitor of
PKMzeta used to validate its critical role in long-term memory may act
nonspecifically to disrupt proteins other than PKMzeta (18). Until recently, these
reports cast doubt on the central role of PKMzeta in LTP maintenance. However the
latest investigation into this process has now supplied definitive evidence that in
these PKMzeta null mice, alternative atypical PKMs are able to compensate for
PKMzeta function, thus reinstating PKMzeta as the endogenous mechanism for LTP
maintenance. Tsokas et. al. (19) circumvented the use of potentially problematic offtarget effects of ZIP by synthesizing an antisense RNA to efficiently degrade and
Knock-Down (KD) both PKMzeta and its closely related family members, Protein
Kinase M Delta and Iota (PKMdelta and PKMiota). The authors show that in
PKMzeta null mice, long-term memory does indeed remain intact (17,18). However,
when the alternate atypical PKMs are also depleted in these same PKMzeta null
mice, long-term memory is inhibited. Furthermore, in wild-type (WT) mice, depletion
of alternate PKMzeta had no effect on long-term memory. Taken together, these
data confirm that PKMzeta is required to maintain LTP and long-term memory, but
that in the absence of PKMzeta, alternate mechanisms are recruited to perform LTP
maintenance (19).
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At the circuit level, PKMzeta’s role in LTP maintenance has been confirmed in
a wide range of brain regions known to be involved in various types of memory. In
the hippocampus, PKMzeta mediates place memory, spatial learning, and object
recognition (14, 20, 21). Injection of ZIP into the amygdala disrupts hippocampaldependent fear memory in rats, (22) and fear potentiated startle (23). In the rodent
reward centers of the brain, the Ventral Tegmental Area (VTA) and the Nucleus
Accumbens (NAc), ZIP infusion alters cocaine sensitization and reduces memory for
cocaine preference (24). In addition to using PKMzeta inactivation and
overexpression to characterize PKMzeta function, many of these studies have
demonstrated that intracellular PKMzeta protein expression positively correlates with
specific memory retention (assessed behaviorally) and strengthened neuronal
connectivity (assed electrophysiologically) in mice models (20, 21, 22).
A more recent study found that while fear learning paradigms induced
PKMzeta expression in the hippocampi of young control rats, this increase in
PKMzeta was significantly reduced in aged rats. The PKMzeta reduction in aged rats
was associated with cognitive impairment on several behavioral assessments, and
was linked to increased cytosine methylation of the PKMzeta internal promoter loci
(33). Furthermore, PKMzeta expression appears to be critically related to cognitive
performance – both overexpression of PKMzeta and enriched environment improved
cognitive performance in aged rats to a similar degree (33). However, in aged rats
harboring a dominant negative version of PKMzeta, the loss of PKMzeta function
prevented any improvement in performance after enriched environment (33),
demonstrating the direct connection between PKMzeta expression levels and
cognitive performance.
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Overall, while many studies have utilized PKMzeta localization as a tool for
identifying maintenance of spatial memory in the rodent dorsal hippocampus (20),
few have examined the distribution of PKMzeta in the non-human primate brain or
attempted to investigate the role of PKMzeta in the affective processing circuits of
the ventral hippocampus (25).

Protein Kinase M Zeta and Affective Processing in the Hippocampus
Stress and Affective Processing in the Hippocampus
The hippocampus is a key structure in the limbic system with an anterior segment
(homologous to the ventral region in rodents) that mediates affective response to
contextual changes in environment, and a posterior segment (homologous to dorsal
region in rodents) that modulates spatial navigation and memory (26). Extremely
sensitive to stress, hippocampal function is closely associated with affective
disorder, with extensive afferent and efferent connections to limbic structures that
regulate mood and cognition (71), such as the amygdala and ventromedial prefrontal
cortex (vmPFC) (95). In both clinical and animal models of depression, researchers
have found decreased hippocampal volume, reduced hippocampal activity,
hypothalamic-pituitary axis (HPA) hyperactivity (indicative of hippocampal
dysfunction) and reduced neurogenesis in the dentate gyrus (27-30). In addition,
significant subsets of patients with major depressive disorder present with cognitive
deficits, which can be recapitulated by inducing hippocampal lesions in nonhuman
primates (31, 32).
Given the large number of studies validating the role of the hippocampus in these
processes, we aim to examine if PKMzeta expression can be used as a marker for
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LTP and information storage integrity in these pathways. Two recently published
reports support the relevance of PKMzeta in both cognitive and affective processing
in the hippocampus. The first, by Hara et. al. (33) is particularly relevant for its use of
the rhesus monkey as a model organism to examine the connection between
PKMzeta subcellular localization and performance on cognitive and memory tasks.
This study looked at perforant spines in the dentate gyrus of aged monkeys and
found decreased density of synaptic GluA2 spines co-expressing PKMzeta
compared to young monkeys – a deficit that correlated with impaired recognition
memory (33). They found that the total densities of PKMzeta in dentate gyrus
dendritic spines significantly correlated with both acquisition and performance on a
delayed nonmatching-to-sample memory (DNMS) task, where monkeys with higher
PKMzeta densities learned the task more rapidly and more accurately (33).
The second study utilized a rodent model of PTSD called re-stressed SPS to show
that hippocampal PKMzeta can mediate anxiety and depressive behaviors related to
this disorder (34). By modifying the classical SPS paradigm for modeling PTSD in
rats to include a re-exposure to the original stressful context, the authors were able
to more fully recapitulate PTSD symptomology in their subjects, resulting in impaired
extinction of contextual fear, enhanced glucocorticoid negative feedback, and
increased anxiety-like behavior (34). In re-stressed SPS rodent subjects, the
authors observed a 3x increase in PKMzeta protein and PKMzeta mRNA transcripts
in the hippocampus compared to control animals correlating with enhanced
depressive or anxiety-like behaviors (34). Next, they found that inhibiting PKMzeta
by administering ZIP into the hippocampus alleviated these depressive and anxietylike responses in re-stressed SPS animals while not significantly affecting these
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same measures in control animals (34), suggesting that PKMzeta-dependent LTP
mediates these affective responses in the hippocampus.
Given these findings, we intend to utilize PKMzeta as a marker for LTP maintenance
in the non-human primate hippocampus in order to characterize its role in cognition
and affective processing. Our unique and extensive non-human primate brain tissue
bank contains whole brain slices from subjects with a wide range of experimental
and developmental conditions, most notably Early Life Stress (ELS) rearing
paradigms. A series of studies has provided a mounting body of evidence that ELS
may confer susceptibility to psychiatric disorder later in life (35). Given its importance
in the pathophysiology of affective disorder, we aim to determine the effects of ELS
on PKMzeta expression in the hippocampus.

A Putative Role for Protein Kinase M Zeta in the Pathophysiology of
Affective Disorders
Early Life Stress is a Risk Factor for Affective Disorder
Early life stress (ELS) exerts a profound influence on behavior and physiology,
putting victims at risk for depression, anxiety disorders and substance abuse (3538). Indeed, ELS not only increases the risk for developing these disorders later in
life, but may also increase the likelihood of comorbidity and resistance to clinical
treatment (39-42). In order to examine the effects of early life adversity, our
laboratory has developed and characterized the Variable Foraging Demand (VFD)
model of ELS in bonnet macaques (43). In the VFD model, mother-infant dyads are
presented with unpredictable variations in the ease of food accessibility. Using
foraging carts, food is either readily accessible to the mother (low foraging demand)
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or more difficult to obtain (high foraging demand). This unpredictability leads to
maternal neglect of the infant, generating a translational model of human anxiety and
mood disorder in the offspring (44-48). These subjects have psychological
symptoms similar to those in patients with anxiety and mood disorders: blunted
affect, diminished capacity for affiliative engagement, and social subordinance (71).
Using this paradigm, we have found significant neurobiological alterations in the
central nervous system and peripheral tissues post-ELS conditioning that may
underlie its capacity as a major risk factor for affective disorders into adulthood.
These stress-related abnormalities in VFD versus non-VFD animals include: altered
monoamine neurotransmission (43,45,49), impaired hippocampal neurogenesis (50),
maladaptive behavioral response to acute stressors (51, 52), abnormal regional
activation via MRI imaging (53), and neuroanatomical changes including reduced
hippocampal size (54). Thus, by correlating hippocampal PKMzeta
neuroimmunological signal intensities with previously obtained behavioral data from
this same cohort, we can delineate the neurobiological phenotype of altered
hippocampal processing in the NHP model of ELS -- effectively linking the
distribution and activity of the molecular substrate of L-LTP to its behavioral and
physiological manifestations.

Methods:
Non-Human Primates
Males:
Variable Foraging Demand Rearing Procedure: Mother-infant dyads were grouphoused in pens of 5–7 dyads each, and stabilized for at least 4 weeks prior to VFD
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onset (74). After infants reached at least 2 months of age, dyads were subjected to a
standard VFD procedure that involved 8 alternating 2-week blocks in which maternal
food was readily obtained (LFD) or more difficult to access (high foraging demand;
HFD). During HFD conditions, the mothers had to find food by digging through clean
wood-chip in a foraging cart. Food can be accessed by mothers through apertures in
the sides of the foraging cart. In the control non-VFD condition, the mothers' food
access was continuous. Adequate food was always available under both conditions,
and there were no differences in weight between VFD and non-VFD mothers or
infants. However, the unpredictability of foraging conditions putatively prevented
VFD mothers from adequately attending to their infants. The early-life stress
paradigm putatively occurs through the disruption of normative patterns of maternal
rearing and infant attachment (45). After infancy, no experimental manipulations
occur that may confound the VFD-rearing effects.

Females:
Adult female bonnet macaques were matched based on age, weight, social rank,
and timing of menstruation, and randomized to a Control pen (n = 6) or a Stress pen
(n = 6).
Separation Stress: Using the chronic stress paradigm developed in rhesus
macaques, we exposed subjects in the Stress pen to social isolation for two days
followed by social reunion on the remaining 5 days, repeated for a total duration of
15 weeks. The monkeys in the Control pen remained in social housing for those 15weeks.
Fluoxetine: During this period, half the subjects in each pen (Control-Drug and
Stress-Drug groups) were treated with the selective serotonin reuptake inhibitor
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(SSRI), fluoxetine. In order to minimize the stress of administration, we used Prozacweekly preparation (Eli Lilly Corp.), at a dose of 13.5 mg/kg infused via nasogastric
tube (NGT) under sedation (ketamine 5 mg/kg and xylazine 1 mg/kg), once per week
for 15-weeks. This dose was equivalent to a daily dose of 2 mg/kg of the drug. The
remaining half (Control-Placebo and Stress-Placebo) received the same treatment
with saline placebo via NGT.
Sacrifice: All groups were injected with the thymidine analog bromodeoxyuridine
(BrdU) (100 mg/kg/day, I.V.) under ketamine/xylazine sedation for 5 days during
week-7 of intervention (Stress/Control+Drug/Placebo) and then sacrificed by
transcardiac perfusion with normal saline (500 ml/kg) followed by 4%
paraformaldehyde (500 mg/kg) under deep anesthesia with pentobarbital (15 mg/kg,
I.V.) on week-16 of interventions.

Behavioral Measures of Emotional Reactivity
Each animal was individually exposed briefly to an intruder, a fear-stimulus which is
a variation of a previously detailed masked intruder paradigm (46).
Males were singly housed in holding cages and the “intruder” entered into the pen
and stood about six feet in front of the cage making direct eye contact with the
monkey. Emotional responsivity was rated by two experimenters blind to Rearing
status using a 3-point scoring scale. To receive a score of one for intruder distress,
subjects exhibited “confrontational” behaviors including: fang-baring, growling, direct
eye contact, pilo-erection, ear flexing, cage shaking, and mouth gaping. The least
distressed response received a score of “three” which was characterized by an
animal that was minimally confrontational, averting eye contact, submissive and
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displaying lip smacking, receding to the back of the cage and exhibiting “timidity” in
response to the intruder. A score of two describes a subject with intermediate or
alternating levels of both confrontational and timid behaviors. One hundred percent
inter-rater reliability was observed for the intruder behavioral scoring system.

Genotyping:
Genotypes were determined by PCR amplification followed by size fractionation on a
2% agarose gel (75). Primers used were CAG CAC CTA ACC CCC TAA TGT CCC
TG and GAT TCT GGT GCC ACC TAG ACG CCAG. Each 10 μl reaction contained
20 ng DNA, 1 μM of each primer, 1 M betaine, 10 μM dNTPs, and 0.1 unit KlenTaq
polymerase, in manufacturer's PC2 buffer. Cycling parameters were 95°C for 5 min
followed by 30 cycles at 95°/72° for 30 and 60 s respectively, using an MJR thermal
cycler.

Neurohistology:
PKMzeta and BDNF Fluorescent: Left brain sections cut to 40Mm thickness were
rinsed three times (5min) in PBS, pH 7.4, transferred to .2% PBST to permeabilize.
Sections were then incubated for 10 min with 0.1% glycine in PBS to quench free
aldehydes, and rinsed with PBS for 10 min. The sections were then incubated in
blocking buffer (5% normal goat serum in PBS) for 1 h and then overnight in primary
antibody (either PKMzeta or BDNF @ 1 : 200) in blocking buffer (a–c), or blocking
buffer alone as control (d). The sections were then rinsed in PBS, four times for 20
min each and incubated with goat anti-rabbit Alexa Fluor 488 (1 : 200) in blocking
buffer overnight on a rotator at room temperature in the dark. The sections were
rinsed three times in PBS, washed in distilled water and mounted with DAPi
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Vectashield Mounting Medium on glass slides with Prolong Gold (Molecular Probes,
Eugene, OR, USA). Negative control was hippocampal tissue without primary
antibody.
PKMzeta Peroxidase: Sections of the left hippocampus was removed from
cyroprotectant, heat-induced epitope retrieval boiling in citrate buffer ph 6.0, washed
in .2% PBST, peroxidase activity quenched with 2% H202, blocked in Normal
Serum, incubated in Primary Antibody @ 1:500 (Rabbit Anti-PKMzeta, Provided by
Dr. Todd Sacktor, SUNY Downstate) for 72hrs, washed in .2% PBST, Incubated in
Secondary antibody @ 1:200 (Biotinylated Goat-Anti Rabbit, Vector Labs), Incubated
in avidin-biotin solution (ABC elite, Vector Labs), chromagen developed using DAB
(vector labs), mounted on subbed slides, counterstained with Neutral Red (vector
labs), dehydrated, cleared, and coverslipped with DPX mountant (Sigma). Negative
control was hippocampal tissue without primary antibody.

Quantification of Average Signal Intensity:
Hippocampal slides were imaged with using an Olympus BS 52 research
microscope fitted with the Olympus DP72 camera at 10x. In order to achieve
appropriate images for quantification, images had to be processed before cellcounting program could be applied to optimize resolution, artifacts, and uneven
fluorescence. These parameters were optimized for each group of control and
experimental animals to account for differences in tissue quality. Images were
analyzed using ImageJ to quantify PKMzeta or BDNF-labeled cells. Briefly,
background noise was subtracted using averaged ROI measures from blank slide,
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image was converted to grayscale, and each subregion of the hippocampus was
traced out using rhesus monkey atlas (no bonnet atlas exists).
Mean PKMzeta Signal Intensity by hippocampal subregion: Adapted from Dr.
Sacktor’s methods, ROIs of each subregion were traced out, and mean signal
intensity was calculated using ImageJ analysis software.

Figure 4: Example of ROIs traced for each hippocampal subregion. Image shows Control Animal
(Non-VFD, Long allele) PKMzeta IF test, showing localization of PKMzeta in green in hippocampus.
Magnification 4x. Abbreviations: Dentate Gyrus (DG), Cornu Ammonis 3 (CA3), Cornu Ammonis 1
(CA1)

ImageJ Method Validation: Protocols were validated using independent rater
counts. Two independent raters, blind to experimental condition of animal,
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conducted all measurements of total PKMzeta and BDNF counts manually. The total
number of unambiguously labeled PKMzeta+ or BDNF+ cells in each sub-region was
counted. For both counts, either ImageJ-generated or manual, the total number of
counted cells was divided by the volume of the subregion (area of each region
measured by ImageJ in µm X 40 µm thickness before post-mounting shrinkage of
50%–70%) (see Figure 5). Rates of labeled cells were expressed as a density per
mm3 of the given subregion. Images taken using an Olympus BS 52 research
microscope fitted with the Olympus DP72 camera.
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Figure 5: Validation of ImageJ PKMzeta+ Cell Counting Method Right graph shows comparison of
manual count vs. ImageJ count over 6 separate specimens. Left graph shows correlation between two
counting methods. (p = 0.0006)

Statistical Analysis:
Males: PKMζ Intensity Signal in Subregions of the Nonhuman Hippocampus: A
General Linear Model (GLM) was performed in the males using group [VFD short
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(n=4), VFD long (n=2), and LFD long (N=4)] as the categorical variable, based on
the subjects’ serotonin transporter gene (STG) polymorphism status. No subjects
were available for the” LFD -short group”, which prohibited use of a factorial ANOVA.
Subregions of the hippocampus were used as repeated measures. Post-hoc effects
were examined using Newman-Keuls testing.
Females: A GLM was employed in normally reared females using concurrent stress
versus no stress as the categorical variable and hilar PKMZETA mean signal
intensity in the hilar subregion of the hippocampus as the dependent variable. Age
[years: mean (SD) = 9.13 (3.20)] and weight [kg: mean (SD) = 8.58 (3.03)] were
confounds and not used as covariates.
Relationship of Hippocampal Subregional PKMzeta to Behavioral Response to a
Human Intruder: For males possessing PKMzeta mean signal intensity data, acute
behavioral response to a human intruder, prior to sacrifice, was grouped into
confrontational (N=3) or timid (n=6). Using a GLM, the categorical variable was
defined by nature of acute behavioral response, confrontational versus timid,
whereas subregions of the hippocampus were used as repeated measures.
Interaction of Concurrent Stress an Serotonin Transporter Gene Polymorphism:
Effect of SSRIs A GLM was performed using two categorical variables – Condition:
No Stress + placebo (N=4), Stress + placebo (n = 7) and stress + fluoxetine (N=4) –
whereas the second categorical variable was serotonin transporter gene
polymorphism [short (N = 7) versus long (N = 8)] and using a factorial ANOVA, their
interaction. The repeated measures were PKMzeta mean signal intensity for the hilar
and CA3 hippocampal subregions.
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Results:
Early Life Stress Interacts with Short Allele of Serotonin Transporter Gene
to produce PKMzeta deficit across all Hippocampal Subregions in Male
NHPs
Our first specific aim was to detect and quantify average PKMzeta signal intensity in
the NHP hippocampus across differentially reared subjects. Using a subset of our
male NHP cohort (N=10), we first utilized IHC to detect and quantify the average
signal intensity of PKMzeta protein in postmortem NHP fixed hippocampal tissues.
Using the methods described above, each hippocampal subregion was traced out
according to the rhesus macaque brain atlas (Figure 4). We next compared the
average PKMzeta signal intensity in six hippocampal subregions across three
groups: Low Foraging Demand (LFD) + Long Allele Serotonin Transporter Gene
(STG), VFD + Long STG, and VFD + Short STG. There was an overall group effect:
(Group Effect F(2, 7)=30.36 p=.0.00035)–there was a marked reduction in
PKMZETA signal mean intensity in the VFD-short allele group versus the other two
groups, whereas the VFD-long allele and LFD-long allele were not statistically
distinguishable. For every hippocampal subregion the identical pattern of
differences was evident on post-hoc testing (indicated by the asterisks in the figure
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below). Mean age of subjects (N=9; one value missing) = [mean (SD) = 8.88 (1.23)
years] whereas mean weight of subjects [mean (SD) = 9.11 (2.83) kg]. No PKMzeta
variable was significantly related to weight or age and therefore these were not used
as covariates. Thus, there was a highly significant STG genotype x rearing effect –
average PKMzeta signal intensity was severely reduced in all six hippocampal
subregions in the VFD + Short STG group (Figure 6).

Group Effect: F(2, 7)=30.36 p=.0.00035
Vertical bars denote +/- standard errors
STG = serotonin transporter gene * univariate testing: p < 0.05
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VFD short allele STG N = 4
VFD long allele STG N =2
LFD long allele STG N = 4
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Figure 6: A combination of ELS + Short STG leads to reduced average PKMzeta signal intensity
across all six subregions of the hippocampus measured.
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A

B

Figure 7: Reduced PKMzeta expression in VFD Short STG (A) Shows VFD Short STG Allele subject
PKMzeta peroxidase test for intracellular localization, showing PKMzeta in brown in CA3 region.
Magnification 40x. (B) Shows Control Animal (Non-VFD Long allele)

These results demonstrate that serotonergic signaling mediates a severe deficit in
hippocampal PKMzeta expression in ELS subjects. Notably, neither ELS rearing nor
Short STG allele alone was enough to affect PKMzeta expression. However, ELS in
combination with the Short STG allele leads to a PKMzeta deficit. This is partially
consistent with our main hypothesis, that ELS would negatively affect PKMzeta.
However, this effect appears to be mediated through serotonergic alterations.
Interestingly, in a previous study (77) we have reported that VFD animals experience
abnormal serotonin neurotransmission to forebrain regions from midbrain
serotonergic nuclei. Given these results, we posit that while this effect is not
sufficient to reduce PKMzeta in adulthood on its own, additional perturbations to
serotonin signaling due to impaired serotonin transporter function can cause
significant attenuation in PKMzeta expression. These results then lead us to ask if
reduced PKMzeta expression in VFD + Short STG animals was associated with
changes in behavioral phenotypes.
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Decreased PKMzeta Signal Intensity in VFD + Short STG subjects is
Correlated with Behavioral Timidity
We next set to investigate if there is a relationship between hippocampal PKMzeta
expression observed in the VFD + Short STG and our previously obtained behavioral
measures in these subjects. We hypothesized that reduced PKMzeta would translate
to changes in behavior that may stem from reduced LTP maintenance, and in turn,
reduced capacity for hippocampal processing. When we examined average
PKMzeta signal intensity across all 6 subregions of the hippocampus and compared
these values to our behavioral measures of emotional reactivity, we found a
significant correlation between reduced PKMzeta expression and behavioral timidity
– a maladaptive, anxiety-like behavior in male bonnet macaques (Figure 8). An
overall group effect was observed [F(1,7) = 6.29, p = 0.04] indicating that the
confrontational nature of response was associated with greater PKMzeta signal
overall in comparison to the timid group. In addition, a repeated measures by group
effect was observed [F(5,35) = 3.02, p = 0.022]. Using post-hoc t-tests, significant
group effects were noted for the zona moleculare, dentate gyrus and CA3
subregions of the hippocampus (see * in the figure below) whereas differences
tapered off toward the subiculum. Group effects remained significant when
covarying for weight whereas repeated measures x group effects remained
significant when covaried for age. Timidity is described as a subordinate behavior,
with the subject displaying low emotional reactivity to direct confrontation with an
intruder. This is in contrast to the more typical male bonnet macaque response – a
demonstration of confrontation and distress at an intruder. Furthermore, subjects
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that displayed a confrontational response to intruder had significantly higher
PKMzeta expression across all hippocampal subregions. Together, these results
suggest that PKMzeta levels in the hippocampus are linked to affective processing –
lower PKMzeta is associated with anxiety-like behaviors.

Repeated Measures x Group Effect: F(5, 35)=3.02, p=.022
Vertical bars denote +/- standard errors
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Figure 8: Reduced PKMzeta expression is associated with anxiety-like behaviors in response to
intruder confrontation across all hippocampal subregions in NHP males

Chronic Adult Separation Stress Leads to Reductions in Average PKMzeta
Signal Intensity in the Hilus Region of the Female NHP Hippocampus
In order to compare the relative effects of ELS versus chronic adult stress, we next
investigated the effects of adult stress (N=4) on average PKMzeta signal intensity in
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our female cohort of NHPs compared to non-stressed control animals (N=7).
Interestingly, we found that concurrent, chronic adult stress severely reduces
average PKMzeta signal intensity in the NHP hilus region of the hippocampus (p =
.018) (Figure 9) in female subjects. Due to time constraints, we were not able to
quantify all six subregions of the female NHP hippocampus. However, in our
analysis with the male cohort, all six subregions followed the same correlative
pattern, with no regional effect differences. For this reason, we used the hilus and
CA3 regions in the female NHP subjects as representative ROI. The concurrent
stress condition was associated with a significant reduction in hilar subregion of
PKMZETA signal mean intensity (see stats in Figure 9). Overall, while ELS alone did
not significantly affect PKMzeta expression later in life (Figure 6), concurrent stress
does affect PKMzeta expression.
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Covariate means:
Age at Sac: 8.58 years

stress/nostress
Current effect: F(1, 9)=8.16, p=.018
Vertical bars denote +/- standard errors
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Figure 9: Concurrent Adult Stress reduces PKMzeta Average Signal Intensity in Female NHP Hilus
Control animals did not undergo any stress paradigms and were normally housed. Stress animals were
subjected to the standard separation stress paradigm, described in Methods.

The Short STG allele leads to decreased PKMzeta expression in the Hilus +
CA3 Subregions of Female Stressed NHP Hippocampus compared to Long
STG Allele Subjects
Having established that concurrent stress decreases PKMzeta expression in the
hilus region of Long allele STG subjects, we next asked if STG genotype modulates
PKMzeta expression in the female in a similar fashion as it did in the male cohort.
Thus, we looked at PKMzeta signal intensity in the hilus and CA3 regions of female
subjects that underwent concurrent adult stress and examined the effects of the
Short STG allele vs. the Long STG allele. We found a highly significant correlation
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between the Short STG allele and decreased PKMzeta signal in the hilus and CA3
regions of the hippocampus, indicating that in animals experience chronic adult
stress, the Short STG allele mediates a further reduction in PKMzeta expression.

Covariate means:
Age: 6.9 years
Weight (kg): 5.1
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Group effect: F(1, 3)=95.294, p=.0022
Vertical bars denote +/- standard errors
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Figure 10: STG genotype Mediates Average PKMzeta Signal Intensity in Concurrently Stressed
Adult Female NHP. Figure shows the PKMzeta signal intensity means for the Hilus + CA3 region, for both
Short STG allele subjects and Long STG allele subjects.

Increasing Hippocampal Serotonin via Fluoxetine Increases PKMzeta
Expression in Hilus of Chronically Concurrently Stressed Short STG NHP
Female Hippocampus Compared to Placebo Stressed Short STG Subjects
Next we observed how PKMzeta expression would be affected by administration of
the Selective Serotonin Reuptake Inhibitor (SSRI) Fluoxetine, a pharmacological
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agent that blocks the serotonin transporter, increasing the amount of extracellular
serotonin available and potentiating the signal strength of serotonergic transmission.
Based on our findings, STG genotype plays a role in modulating PKMzeta
expression after both ELS (Figure 6) and adult concurrent stress (Figure 10). We
thus hypothesized that increasing the amount of serotonin available in the
hippocampus via fluoxetine would increase the amount of PKMzeta signal detected.
We obtained the average PKMzeta signal intensity of the Hillus + CA3 regions in
NHP females and compared these measures across six groups: No Stress +
Placebo (Short and Long STG allele); Concurrent Adult Stress + Placebo (Short and
Long STG allele); and Concurrent Adult Stress + Fluoxetine (Short and Long STG
allele). SSRI treatment, for the short allele, has no discernable effect whereas for the
long allele, SSRIs appear to reduce PKMZETA signaling into the range of values
observed with the short allele, and is significantly less (see asterisk) than the other
two long allele groups – No Stress + Placebo and Stress + Placebo. The fluoxetine
effects are counterintuitive in comparison to human data in which SSRIs appear to
perform optimally in depressed subjects with the long allele, and not to reduce the
expected value (1). The results are shown in Figure 11; on the left side of the graph,
the measures for the Short Allele STG animals were consistent with our hypothesis.
Administration of the SSRI fluoxetine increased PKMzeta expression to Control
levels in the Stress + Short Allele STG group. Thus, increasing serotonin also
increased PKMzeta signal intensity in these two hippocampal subregions in
stressed, Short STG Allele subjects. Interestingly, we found a contradictory effect in
the Long STG allele group. Although concurrent adult stress did reduce PKMzeta
expression compared to control animals (as previously shown), subjects that
received fluoxetine had severely reduced levels of PKMzeta. This was an
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unexpected result, and suggests that fluoxetine has differential effects on PKMzeta
expression in Short versus Long STG allele stressed subjects.
stress*genotype interaction
Current effect: F(2, 9)=13.75, p=.0018
Vertical bars denote +/- standard errors
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Figure 11: Fluoxetine increases PKMzeta expression in Hilus + CA3 compared to Placebo in
Concurrent adult stress + Short STG allele female NHPs, but NOT in Long STG allele subjects.

Increasing Hippocampal Serotonin via Fluoxetine Increases BDNF
Expression in Hilus of Concurrently NHP Female Hippocampus Compared
to Placebo Stressed Subjects
Finally, we used IHC to detect and quantify BDNF average signal intensity in the
female NHP hippocampus in order to determine if BDNF expression is linked to
serotonergic signaling in these same subjects. In our previous study, we outlined a
putative model for serotonergic dysfunction in the VFD NHP, in which attenuated
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serotonin neurotransmission from the dorsal raphe nucleus to forebrain limbic
regions resulted in compromised neurotrophic activity (77). This model is drawn from
preclinical reports (59,60) that the main trophic factor responsible for maintaining
neuronal growth and integrity, BDNF, is intimately connected with serotonin
signaling. Thus, we hypothesized that increasing hippocampal serotonin via SSRI
fluoxetine administration would result in increased BDNF expression. In Figure 12,
we show that BDNF expression is significantly increased in the Hilus of concurrently
stressed female NHPs with fluoxetine, compared to subjects given a placebo. Thus,
when serotonin is putatively increased, BDNF is also increased. This data supports
our hypothesis that low serotonin may lead to low BDNF levels, leading to reduced
neurotrophic activity and LTP capacity through BDNF’s mediation of PKMzeta.
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Group Effect: F(1, 5)=3.72, p=.11, partial Eta Squared = 0.42
Effective hypothesis decomposition
Vertical bars denote +/- standard errors
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Figure 12: Regardless of STG genotype, SSRI Fluoxetine increases BDNF expression in concurrently
stressed female NHP hilus, compared to subjects receiving placebo.

Conclusions
1. In Male NHPs, ELS + Short STG allele is correlated with PKMzeta
expression deficit across hippocampus, a deficit associated with
anxiety-like behaviors
2. In Normally-Reared Female NHPs, Adult Concurrent Stress Reduces
PKMzeta Expression in the Hippocampus, an Effect Exacerbated by
Short STG allele and Relieved by SSRI administration
3. Hippocampal PKMzeta Expression is Associated with Serotonergic
Function in Both Male and Female NHP Cohorts, Revealing a
Connection to Both ELS and Concurrent Adult Stress
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4. SSRI treatment is Related to Increased BDNF expression in the Female
NHP Hippocampus

Discussion
In Male NHPs, ELS + Short STG allele is correlated with PKMzeta
expression deficit across hippocampus, a deficit associated with anxietylike behaviors
In this study, we first present data indicating that ELS in combination with the Short
STG allele negatively regulates PKMzeta expression in the male NHP hippocampus.
Our initial hypothesis predicted that ELS would lead to decreased PKMzeta in the
adult subjects – however we found that ELS alone was not sufficient to produce a
PKMzeta deficit into adulthood, when PKMzeta expression was measured across six
hippocampal subregions via IHC. Interestingly, in VFD subjects harboring the short
STG allele, we found significant decreases in PKMzeta expression compared to VFD
subjects with the Long STG allele or Control animals. These data indicate that
PKMzeta expression in ELS animals may be mediated directly by serotonergic
signaling. These findings extend our previous work showing gene by environment
(short allele by ELS) effects in nonhuman primates exposed to VFD-rearing for
reduced corpus callosum cross sectional area (77) and CSF CRF concentration
elevations (78). Additionally, these reports are consistent with rhesus macaque work
from other groups showing a similar short allele by ELS interactions (i.e., peer
rearing) on HPA reactivity in response to stress (79-81). Several studies
investigating the influence of risk factors for depression and other stress-related
psychiatric disorders have found a role for the short allele of the serotonin
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transporter linked polymorphic region (5-HTTLPR) in increased vulnerability to these
diseases (82). These studies suggest that the short STG allele may be linked to
increased sensitivity to stress, starting early in life (83). It has found that the short
allele STG genotype is linked to increased anxiety-related behaviors beginning in
development, (84), and continuing into adolescence and early adulthood, providing a
valid developmental model for understanding how the 5-HTTLPR short allele might
modulate stress reactivity.
In the current study, we find that the short STG genotype mediates reduced
PKMzeta expression in the hippocampus when present in animals reared in a VFD
ELS paradigm, suggesting that this allele may also be contributing to LTP
maintenance and cognitive processes in these subjects. Supporting this hypothesis,
we found that reduced PKMzeta expression in these same subjects was associated
with timidity and anxiety-like responses to an intruder stressor task. This timid,
maladaptive response to intruder stress has been found to be indicative of an
increased susceptibility to various forms of affective disorder (85). Indeed, based on
a wide body of work, a conceptual framework has been developed that suggests that
differences in behavioral strategies to deal with this same intruder paradigm may
have implications in terms of vulnerability to stress-related pathologies (85). Here,
we report that STG genotype interacts with ELS exposure to reduce PKMzeta, which
directly predicts the patterns and types of behavioral responses that NHP subjects
exhibit to an acute stressor. This finding supports the hypothesis that PKMzeta
expression in the hippocampus may be used as a marker of affective processing,
and may represent a potential target for therapeutic applications in the treatment of
psychiatric disorders related to stress.
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In Normally-reared Female NHPs, Adult Concurrent Stress Reduces PKMzeta
Expression in the Hippocampus, an Effect Exacerbated by Short STG allele
and Relieved by SSRI Administration
Another intriguing result from this study was the finding that adult concurrent stress
reduces hippocampal PKMzeta expression in normally-reared female NHPs. This
finding is consistent with our previous work on this same female NHP cohort,
showing a variety of stress-related neurobiological alterations (50). Notably, we have
published data showing that adult concurrent stress leads to depression-like
anhedonia behaviors in these animals (50) – a finding that supports our current
finding of PKMzeta being linked to behavior (in male NHPs) and its role as a marker
of affective processing. In that paper, exposure of monkeys (Stress-Placebo group,
n = 3) to repeated social separation stress led to gradual increases in behavioral
scores for anhedonia (a behavioral composite of collapsed postures, inactivity, and
blank stares) and decreases in scores for hierarchy (total subordinate behaviors
subtracted from total dominant behaviors) (50). The bonnet macaques exposed to
repeated social separation stress displayed increases in anhedonia that involved a
cluster of symptoms typically seen in depressive monkeys (86), including
macaques (87). Critically, this behavioral profile possesses significant face validity
as an analog of clinical anhedonia, a core symptom of major depression (88). The
increases in the anhedonia scores were accompanied by decreases in hierarchy
scores. Social subordinance is a hallmark of both chronic anxiety and depression in
monkeys (86). This behavior of the NHPs in the setting of repeated social separation
stress parallels clinical depression, as interpersonal loss is the predominant trigger
of depression in humans (88) and chronic stress is a major epidemiological risk
factor for major depression and chronic anxiety disorders (88).
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Building on this finding, we next turned to compare the effects of the STG allele in
concurrent adult stress subjects. Based on our pervious findings in the male NHP
cohort, we predicted that the short STG allele would combine with concurrent adult
stress to further decrease PKMzeta expression in the hippocampus of stressed
females.
One of the most important findings in this report is the contribution of STG
transporter genotype in mediating PKMzeta expression in both ELS (male) and
normally-reared animals subjected to concurrent adult separation stress (female). As
discussed above, ELS + short STG allele reduced PKMzeta expression, and was
correlated with anxiety-like behaviors. In our female NHP cohort, we found that while
concurrent adult stress alone affected PKMzeta expression in the hippocampus
compared to control animals. Investigating further, we looked at PKMzeta expression
in Long vs. Short STG allele animals in this cohort of concurrently stressed subjects,
we found that, as in the males, Short STG allele exacerbated the negative effects of
stress on PKMzeta hippocampal expression, even further reducing PKMzeta
expression in both subregions examined (hilus + CA3) below levels found in Stress +
Long STG allele subjects.
In several previous studies, we have reported that administration of the SSRI
fluoxetine improves several depression-like symptoms in this cohort of bonnet
macaque females (50), including measures of neurogenesis and anhedonia-related
behaviors (50). Thus, we utilized this group of SSRI-treated animals in order to
compare PKMzeta expression in these animals versus stressed, placebo-treated
animals. We reasoned that due to our previous findings that serotonin transporter
function is clearly tied to PKMzeta expression in both ELS and normally-reared
concurrent adult stress conditions, increasing serotonin via SSRI treatment would
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increase PKMzeta expression compared to the placebo group. Indeed, we found that
in short STG allele females that were subjected to concurrent adult stress, treatment
with SSRIs increased PKMzeta expression over the levels seen in the placebo-only
stressed group. It is important to note that we did not see the same effect in stressed
animals harboring the Long STG allele – that is, Stress + Long STG allele + Placebo
subjects had higher PKMzeta expression than Stress + Long STG allele + SSRI.
This was an unexpected result, and not consistent with our hypothesis. However, in
a recent study (unpublished results) we have seen several counterintuitive results in
this same cohort of female NHPs between the placebo and SSRI groups, indicating
that fluoxetine affects different groups in unpredictable ways. Much further analysis
and study is needed in order to fully characterize the effects of SSRIs in differential
STG genotype subjects. Nevertheless, there was a significant effect in the Short
STG allele group with PKMzeta expression comparing Placebo vs. SSRI conditions.
Given these results, we have begun to develop a putative model for the connection
between serotonergic signaling and PKMzeta expression in the NHP hippocampus
in stress conditions.

Hippocampal PKMzeta Expression is Associated with Serotonergic
Function in Both Male and Female NHP Cohorts, Revealing a Connection to
Both ELS and Concurrent Adult Stress
Previously, in a NHP model of ELS, our laboratory has found evidence of an
intriguing mechanistic connection between serotonergic neurotransmission to the
hippocampus and PKMzeta-mediated LTP, putatively bridged by the highly important
neurotrophin brain-derived growth factor (BDNF). This relationship between the
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serotonin system, PKMzeta, and BDNF may explain many of the neurobiological
symptoms observed post-ELS, and elucidate the pathophysiology of affective
disorder. One of the major consequences of VFD rearing we have focused on in
our research is dysfunctional serotonin neurotransmission. The serotonergic system
is crucially important to the pathophysiology and the treatment of mood disorders,
and its disruption in ELS may underlie the increased risk of depression and anxiety
(55, 45). Accordingly, one genetic risk factor that contributes to increased
vulnerability to depression is the SLC6A4 serotonin transporter gene, which is critical
to the regulation of serotonin function throughout the brain. The “s” allele encodes an
attenuated promoter segment, and is associated with reduced transcription and
functional capacity of the serotonin transporter (89). In bonnet macaques, this
endogenous single nucleotide polymorphism is conserved, allowing us to study the
effects of serotonin neurotransmission in our ELS animal model. In our cohort of
VFD and non-VFD subjects, we have reported a gene x environment effect for both
CSF CRF concentration, and amygdala volume (77,78). Thus, the short allele of the
5-HTTLPR is linked with an increased risk for developing symptoms associated
affective disorder after ELS, pointing to the important role of serotonergic signaling in
modulating these processes. Additionally, we have found elevated cisternal, periraphe CSF 5-HIAA in three separate cohorts of VFD animals compared to normally
reared controls, which we hypothesized reflects a form of serotonin
neurotransmission dysfunction specific to ELS (54). ELS persistently activates
stress-mediated circuitry, compromising these networks’ responses to future stress
(1,56). A particularly relevant example of such circuitry is the glutamatergic afferents
emanating from Layer V of the medial prefrontal cortex to stimulate serotonin release
in the midbrain raphe nuclei (57). Stress-induced excess serotonin release may
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trigger an endogenous negative-feedback mechanism mediated by serotonin 5HT1A autoreceptors in the raphe itself (57,58) reducing serotonin projections to
critical forebrain areas such as the hippocampus. In support of this model, we have
previously found that high VFD cisternal 5-HIAA measures correlated with reduced
right hippocampal volume, indicating downstream neurotrophic effects (77). The
mechanisms responsible for these effects, however, are not currently understood. In
the current report, we suggest that stress, both during early life and in adulthood,
negatively affects serotonin signaling, leading to downstream consequences,
particularly with regard to neurotrophic activity.

SSRI treatment is Related to Increased BDNF Expression in the Female NHP
Hippocampus
The current study aimed to determine if PKMzeta, and by extension, LTP
maintenance, has a role in mediating the neurobiological symptoms of ELS-induced
affective disorder. Preclinical studies of the effects of stress suggest a minimum of
four mechanisms by which hippocampal atrophy may result from stress: dendritic
atrophy, synaptic remodeling (synaptic overproduction and pruning), increased
neuronal death, and decreased rates of neurogenesis (90-92), all processes that are
intimately tied to BDNF and serotonergic signaling (59,60). Indeed, hippocampal
volume is closely reliant on the presence of neurotrophic factors such as brainderived growth factor (BDNF) to maintain neuronal growth and survival (59).
Importantly, this key growth factor has a synergistic relationship with the serotonin
system, regulating serotonergic neuronal survival even while serotonin-activated
second messengers modulate BDNF production (59-62). In fact, the hippocampus is
particularly vulnerable to changes in BDNF level; missense polymorphisms in the
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BDNF gene are directly correlated with reduced hippocampal volume (63). These
data imply that reduced serotonin neurotransmission at the hippocampus is directly
linked to reduced volume through BDNF production (60).

BDNF has a Central Role in Memory and Regulates PKMzeta During LTP
As described above, our previous research has suggested a connection between
serotonergic dysfunction precipitated by ELS and reduced neurotrophic activity in the
hippocampus, which is mediated by BDNF. BDNF has a well-documented role in
mediating LTP in the hippocampus (65) and other regions involved in memory, such
as the amygdala (64). Importantly, BDNF has been found to be required not only for
acquisition but also for persistent storage of long-term fear memory (66). In fact,
BDNF can rescue LTP even when protein synthesis is inhibited, demonstrating that
the factor is both necessary and sufficient for expression of synaptic potentiation
(67). A recent study by Sacktor et al. (68) reported a mechanistic explanation for this
finding – in acute mouse brain slices, they showed that inhibition of PKMzeta
reversed this BDNF-dependent form of LTP. Molecular analyses revealed that BDNF
can maintain levels of PKMzeta at the synapse through directly associating with it,
and preventing its degradation, allowing for continued trafficking of AMPARs to the
post-synaptic density even when PKMzeta cannot be synthesized (68). Additional
studies have confirmed this relationship between BDNF and PKMzeta,
demonstrating that BDNF enhances PKMzeta expression, controls PKMzeta nascent
synthesis via translation machinery mTORC1, and also enhances PKMzeta
phosphorylation and activation (69).
In support of our model of BDNF bridging the connection between serotonin and
PKMzeta, here we present evidence that BDNF levels are directly connected with
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serotonergic levels- increasing extracellular serotonin and serotonergic signaling via
SSRI administration increased BDNF expression in the hippocampus of NHP female
subjects for both control and stress conditions.
Taken together, these data lay the foundation for a model in which ELS-related
serotonergic dysfunction leads to reduced BDNF in the hippocampus, compromising
neurotrophic activity and negatively affecting regulation of PKMzeta, the only known
molecule to be necessary and sufficient for LTP and long-term memory storage (70).
While many of the structural and neurochemical consequences of ELS have been
studied, it is not well understood exactly how these changes might translate to the
deficits in cognitive and affective function associated with mood disorders. By
connecting our previous findings of serotonergic dysfunction in the VFD model to the
neurotrophic hypothesis of depression, we conclude that PKMzeta expression may
be negatively affected post ELS in subjects with compromised serotonergic
signaling, and this effect may lead to reduced cognitive and affective processing.

Given these findings, we propose that studies in nonhuman primates provide an
essential tool to understand the molecular mechanisms by which ELS interacts with
the short allele to modify vulnerability to depression and anxiety in humans.
Limitations of the study include the relatively small number of subjects, particularly
for the gene by environment component. However, we acknowledge the preliminary
nature of these findings of the interaction of ELS and the serotonin transporter gene
in PKMzeta expression contributing to maladaptive, anxiety-like behaviors.
Nonetheless, the current study adds to a growing body of data that suggests ELS is
associated with a concert of biological changes that are evident across the lifecycle.
The VFD paradigm provides an important animal model to elucidate the cellular and
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molecular mechanisms by which ELS causes clinically relevant neurobiological
alterations in a translational NHP model.
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